Developing pharmacy services in a home hospital program: The Mayo Clinic experience

被引:5
|
作者
Peinovich, Margaret [1 ]
Darracott, Robert [2 ,3 ]
Dow, Jordan [4 ]
机构
[1] Medically Home, Boston, MA USA
[2] Mayo Clin, Dept Pharm, Jacksonville, FL 32224 USA
[3] Mayo Clin, Coll Med & Sci, Rochester, MN USA
[4] Froedtert & Med Coll Wisconsin, Dept Pharm, Milwaukee, WI 53226 USA
关键词
dispensing; experience; home hospital; innovation; medication management; pharmacy;
D O I
10.1093/ajhp/zxac200
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Purpose Home hospital programs are rapidly becoming a more common patient care model in the market. The impact on hospital pharmacy practices is not well defined. This article describes the development of pharmacy services in a home hospital program in an attempt to help other organizations create their own home hospital pharmacy programs. Caring for acutely ill patients in their home was a novel idea when Mayo Clinic began considering this in January 2020. Since then, the coronavirus disease 2019 (COVID-19) pandemic has rapidly escalated interest in and pursuit of these programs. One question we asked ourselves, and many colleagues are asking us today, is "How does pharmacy fit in?" Through 2 years of active engagement, innovation, and persistence, our team has developed a robust pharmacy presence in the home hospital care team and a well-articulated approach to medication management for our patients. We have tightly aligned and blended our clinical efforts to mirror our typical inpatient and ambulatory care clinical activities. We have also developed and modified our dispensing functions to serve the unique needs of the care model. Conclusion Home hospital medication management is both complex and ripe with opportunities for pharmacy engagement.
引用
收藏
页码:1925 / 1928
页数:4
相关论文
共 50 条
  • [41] Survival of home parenteral nutrition-treated patients: 20 years of experience at the Mayo Clinic
    Scolapio, JS
    Fleming, CR
    Kelly, DG
    Wick, DM
    Zinsmeister, AR
    MAYO CLINIC PROCEEDINGS, 1999, 74 (03) : 217 - 222
  • [42] Q fever endocarditis: The Mayo Clinic experience
    Scott, Jeremy W.
    Baddour, Larry M.
    Tleyjeh, Imad M.
    Moustafa, Sherif
    Sun, Yin Guang
    Mookadam, Farouk
    AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2008, 336 (01): : 53 - 57
  • [43] Thrombophilia Testing Practices: The Mayo Clinic Experience
    Scheckel, Caleb J.
    Pruthi, Rajiv K.
    Marshall, Ariela L.
    Ashrani, Aneel A.
    Chen, Dong
    Heikal, Nahla M.
    BLOOD, 2020, 136
  • [44] Chemotherapy for advanced esthesioneuroblastoma: The Mayo Clinic experience
    McElroy, EA
    Buckner, JC
    Lewis, JE
    NEUROSURGERY, 1998, 42 (05) : 1023 - 1027
  • [45] MAYO CLINIC LIBRARY - AN EXPERIENCE IN REMODELING AND EXPANSION
    KENNEDY, C
    KEYS, TE
    BRENGMAN, JF
    BULLETIN OF THE MEDICAL LIBRARY ASSOCIATION, 1958, 46 (02): : 249 - 269
  • [46] Clinical outcome of home parenteral nutrition: The Mayo Clinic's twenty-year experience
    Scolapio, JS
    Fleming, CR
    Kelly, DG
    Wick, D
    Zinsmeister, AR
    GASTROENTEROLOGY, 1998, 114 (04) : A907 - A907
  • [47] The Program Evaluation of Services in a Primary Care Clinic: Attaining a Medical Home
    Kleinsorge, Christy A.
    Roberts, Michael C.
    Roy, Kimberlee M.
    Rapoff, Michael A.
    CLINICAL PEDIATRICS, 2010, 49 (06) : 548 - 559
  • [48] Diagnosis of autoimmune pancreatitis: The Mayo Clinic experience
    Chari, Suresh T.
    Smyrk, Thomas C.
    Levy, Michael J.
    Topazian, Mark D.
    Takahashi, Naoki
    Zhang, Lizhi
    Clain, Jonathan E.
    Pearson, Randall K.
    Petersen, Bret T.
    Vege, Santhi Swaroop
    Farnell, Michael B.
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2006, 4 (08) : 1010 - 1016
  • [49] Infliximab for the Treatment of Neurosarcoidosis: The Mayo Clinic Experience
    Stitt, Derek
    Aksamit, Allen
    Utz, James
    NEUROLOGY, 2016, 86
  • [50] Myelodysplastic syndrome and pregnancy: The Mayo Clinic experience
    Steensma, DP
    Tefferi, A
    LEUKEMIA & LYMPHOMA, 2001, 42 (06) : 1229 - 1234